Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”

H Pakhchanian et al.COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis

Semin Arthritis Rheum

(2022)

NJ McHugh et al.Autoantibodies in myositis

Nat Rev Rheumatol

(2018 Apr 20)

L.S. Hoff et al.COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey

Rheumatol Int

(2023)

A Gil-Vila et al.COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

Muscle Nerve

(2022)

There are more references available in the full text version of this article.

留言 (0)

沒有登入
gif